Ram Kamineni

Chief Tech/Sci/R&D Officer at KRYSTAL BIOTECH, INC.

Health Technology

Profile

Ram Kamineni is currently working as the Senior VP-CMC & Technical Operations at Krystal Biotech, Inc. Prior to this role, he worked as the Chief Operating Officer at KVK-Tech, Inc.

Ram Kamineni active positions

Companies	Position	Start
KRYSTAL BIOTECH, INC.	Chief Tech/Sci/R&D Officer	2022-06-30

All active positions of Ram Kamineni

Former positions of Ram Kamineni

Companies	Position	End
KVK-Tech, Inc. KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso.	Chief Operating Officer	2021-09-30

See the detail of Ram Kamineni's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ram Kamineni's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
KRYSTAL BIOTECH, INC.	Health Technology

Private companies	1
KVK-Tech, Inc. KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso.	Health Technology